Targeted cleavage of HIV-1 coreceptor-CXCR-4 by RNA-cleaving DNA-enzyme: Inhibition of coreceptor function

Antiviral Research

Volumn 46, Issue 2, 2000, Pages 125-134

  Basu, Shrabani ^a   Sriram, Bandi ^a   Goila, Ritu ^a   Banerjea, Akhil C ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Catalytic DNA; CCR5; Chemokine receptors; CXCR 4; DNA enzymes; HIV 1 coreceptors

Indexed keywords

CHEMOKINE RECEPTOR; VIRUS DNA; VIRUS RNA;

ARTICLE; CATALYSIS; DATA ANALYSIS; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE FUNCTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE;

BASE SEQUENCE; DNA; ENZYMES; HIV-1; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; RNA; RNA, CATALYTIC; SUBSTRATE SPECIFICITY;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; RNA VIRUSES;

EID: 0034036143     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00075-9     Document Type: Article

References (22)

1. Banerjea A.C., Brechling K.A., Ray C.A., Erickson H., Pickup D.J., Joklik W.K. High level synthesis of biologically active reovirus protein σ1 in a mammalian expression vector system. Virology. 167:1988;601-612.
2. Banerjea A.C., Joklik W.K. Reovirus protein σ1 translated in vitro as well as truncated derivatives of that lack up to two-thirds of its C-terminal portion, exists as two major tetramolecular species that differ in electrophoretic mobility. Virology. 179:1990;460-462.
3. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:1999;657-700.
4. Biti R., Ffrench R., Young J., Bennetts B., Stewart G. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat. Med. 3:1997;252-253.
5. Dash B.C., Harikrishnan T.A., Goila R. et al. Targeted cleavage of HIV-1 envelope gene by a DNA-enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion. FEBS Lett. 431:1998;395-399.
6. Dean M., Carrington M., Winkler C. et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1996;1856-1862.
7. Fuerst T.R., Earl P.L., Moss B. Use of hybrid vaccinia virus-T7 polymerase system for expression of target genes. Mol. Cell. Biol. 7:1987;2538-2544.
8. Goila R., Banerjea A.C. Sequence specific cleavage of HIV-1 coreceptor-CCR5 gene by a hammer-head ribozyme and a DNA-enzyme. Inhibition of the coreceptor function by DNA-enzymes. FEBS Lett. 436:1998;233-238.
9. Huang Y., Paxton W.A., Wolinsky S.M. et al. The role of mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1996;1240-1243.
10. Husain S., Goila R., Shahi S., Banerjea A.C. First report of a healthy Indian heterozygous for Δ32 mutant of HIV-1 co-receptor-CCR5. Gene. 207:1998;141-147.
11. Husain S., Goila R., Shahi S., Banerjea A.C. Inheritance pattern of mutant human immunodeficiency virus type 1 coreceptor gene in an Indian family. J. Human Virol. 1:1998;187-192.
12. Joklik W.K. The purification of four strains of pox virus. Virology. 18:1962;9-18.
13. Loetscher M., Geiser T., O'Reilley T., Zwahlen R., Baggiolini M., Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269:1994;232-237.
14. Liu R., Paxton W.A., Choe S. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell. 86:1986;367-377.
15. Nelson M.L., Nelson J.A.E., Kewalramani V.N. et al. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 Δ32. J. Virol. 72:1998;6040-6047.
16. Nussbaum O., Broder C.C., Berger E.A. Fusogenic mechanisms of enveloped virus glycoproteins analyzed by a novel recombinant vaccinia virus based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:1994;5411-5422.
17. O'Brien T.R., Winkler C., Dean M. et al. HIV-1 infection in a man homozygous for CCR5 Δ32. Lancet. 349:1997;1219.
18. Rucker J., Samson M., Doranz B.J. et al. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell. 87:1996;437-446.
19. Samson M., Libert F., Doranj B.J. et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of CCR5 chemokine receptor gene. Nature. 382:1996;722-725.
20. Santoro S.W., Joyce G.F. A general purpose RNA-cleaving DNA-enzyme. Proc. Natl. Acad. Sci. USA. 94:1997;4262-4266.
21. Theodorou, I., Meyer, L., Magierowska, M., Katlama, C., Rouzioux, C., and the Seroco Study Group, 1997. HIV-1 infection in an individual homozygous for CCR5 Δ32. Lancet 349, 1219-1220.
22. Zhang Y-J., Moore J.P.J. Will multiple coreceptor need to be targeted by inhibitors of human immunodeficiency virus type 1 entry? J. Virol. 73:1999;3443-3448.